Ranolazine Product Enquiry

Ranolazine is an antianginal medication. On January 31, 2006, ranolazine was approved for use in the United States by the FDA for the treatment of chronic angina.

Chemical Name:

Ranolazine


Description
(RS)-N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)-propyl]piperazin-1-yl]acetamide
142387-99-3
C24H33N3O4
RANOLAZINE;n-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide;1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethy]piperazine;CVT 303;Ranexa;Renexa;RS 43285-003;1-Piperazineacetamide,N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-
For the treatment of chronic angina. It should be used in combination with amlodipine, beta-blockers or nitrates.
Note :
API/Substances covered by patents are not offered to the countries where valid Patent Law is in force. However, the final responsibility lies with the customer.
back-to-top